Company achieved significant commercial progress in 2024, finishing with total U.S. net product sales revenue of approximately $319 million (unaudited) Company reaffirms peak U.S. net IBSRELA sales re ...
Akebia has since engaged with the FDA on potentially expanding vadadustat treatment to this patient population and has received feedback on a protocol submitted for a Phase 3 cardiovascular outcome ...
After decades of studies and reports on the continuing degradation of Oklahoma's waterways, organizations like Save The Illinois River and Spring Creek Coalition wonder why the data are not being ...